Dementia syndromes - The clinical genetics of dementia

Dementia syndromes - The clinical genetics of dementia - technical

The major dementia syndromes are disorders of abnormal protein aggregation. Both genetic and sporadic forms of each illness exist and overlap has been found with parkinsonian–dementia syndromes. This section surveys the clinical genetics of dementia. See  for a more detailed account.

Potential new treatment for Alzheimer’s disease

By on
amyloid cleared from brain by aducanumab

Aducanumab is an exciting potentially new treatment for Alzheimer’s disease and may possibly be the first potential cure.

A human monoclonal antibody, aducanumab, has been shown to remove amyloid beta plaques from the brains of patients with early or mild Alzheimer’s disease. The drug was more effective at higher doses. This was shown using PET brain scans (see below).


Salsalate may reverse Alzheimer's memory loss

By on

Salsalate a medication mentioned by Hippocrates may reverse Alzheimer's memory loss.

salsalate may treat alzheimer's disease

Salsalate is already used for arthritis but it could bring back memories of people suffering from Alzheimer's disease.

One of the world’s oldest drugs which was first mentioned by Hippocrates in the 5th Century BC could help restore memory in Alzheimer’s patients, scientists hope.



Amyloidosis is an uncommon disease in which a substance called amyloid, composed of fibrous protein, accumulates in tissues and organs, including the liver, kidneys, tongue, spleen, brain and heart.